Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 299, pseudogene (RNU6-299P) is a genomic sequence in humans classified as a pseudogene related to the U6 small nuclear RNA family. U6 small nuclear RNAs (snRNAs) are integral components of the spliceosome, a ribonucleoprotein complex responsible for intron excision from pre-mRNA; however, pseudogenes like RNU6-299P are nonfunctional genomic elements formed through retrotransposition or duplication events and do not yield functional RNAs. RNU6-299P does not code for a protein or produce a structural RNA with biological activity. It has no established role in cellular function, therapeutic targeting, or disease. Its relevance is limited to genomic studies of pseudogene formation and retrotransposition dynamics in the human genome. RNU6-299P is a human pseudogene, not a functional receptor, enzyme, or molecular therapeutic target. It has no known aliases beyond RNU6-299P, no biological function, disease association, or role in drug interactions, mechanisms, biomarkers, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 299, pseudogene (RNU6-299P).